Guests:
Laura Hercher, Genetic Counselor, Sarah Lawrence College
Nathan Pearson, Genomicist; Founder, Root Deep Insight
Chapters:
0:00 Impact of DTC BRCA approval
8:20 Questioning the NIH’s All of Us Research Program
23andMe steals the headlines yet again.
“If somebody is worried about breast cancer susceptibility in their family, they should certainly not be using this test.”
That’s our monthly commentator and genetic counselor, Laura Hercher, talking about BRCA going DTC. But wait a minute. Then she says the test could be good in some instances.
Fellow commentator Nathan Pearson cracks us up with his new term for the NIH’s All of Us Research Program. We question the big science project after the New York Times reveals that several major institutions, including Geisinger and Kaiser, are pulling out.
It’s Nathan and Laura back to offer their inside take on the lead genomic stories of the past month.
And no matter what, we won’t mention 23andMe again next month. We hope.
